NIBRT SFI-IRC Pathway success
Congratulations to Dr. Alan Costello who has been awarded over €590,000 under the SFI-IRC Pathway Programme awards announced last week by Minister for Further and Higher Education, Research, Innovation and Science, Patrick O’Donovan TD. The SFI-IRC Pathway programme is a collaborative initiative between Science Foundation Ireland (SFI) and the Irish Research Council (IRC) to support early-career research across all disciplines and to encourage a cohesive research ecosystem in Ireland. Minister O’Donovan said: “This Pathway funding will help facilitate a defined journey from post-doctoral research to independent researcher. Bridging this gap is a challenging but critical milestone, and the research selected for investment will address key challenges and opportunities, ranging from new therapies for Parkinsons to the development of sustainable supercapacitors.”
Dr. Costello’s project will investigate RNA delivery vectors for transfer RNA therapeutics, with the potential to yield new biomolecules to treat human genetic disease where no current therapeutic exists. Speaking about the award Costello said: “I am thrilled to begin my transition to an independent researcher with the help of the SFI-IRC Pathway program and NIBRT. The project will combine directed evolution and synthetic biology methods I’ve gained through my Postdoctoral work to develop new RNA therapeutics.”
Dr. Fiona Killard-Lynch commented: “As the Director of Research and Innovation at NIBRT, I am delighted to welcome Dr Alan Costello as a future research leader through the SFI-IRC Pathway Programme. Developing future leaders in bioprocessing in Ireland is crucial for maintaining and advancing our position in the global biopharmaceutical industry. By investing in their professional development and that of their teams, we secure the future of cutting-edge research and manufacturing excellence in Ireland, fostering economic growth and improving healthcare outcomes worldwide. We are proud of Dr Costello’s achievements and look forward to his impactful research.”
Find out more about research at NIBRT here
